Table 4.
Comparison between iDC and mDC lymph node uptake
| Patients | DC i/m × 106 | Isotope | Max uptake (%) * | |
| G.C. (no. 1) | i | 6 | 99mTc-HMPAO | 0.22 |
| G.C. (no. 1) | i | 6.9 | 99mTc-HMPAO | 0.05 |
| G.L. (no. 2) | i | 9 | 99mTc-HMPAO | 0.05 |
| P.A.M. (no. 3) | i | 6 | 111In-Oxine | 0.42 |
| T.N. (no. 5) | m | 5.6 | 99mTc-HMPAO | 1.75 |
| P.I.M. (no. 4) | m | 12 | 99mTc-HMPAO | 0.53 |
| PA.M. (no. 3) | m | 7 | 111In-Oxine | 3.14 |
| S.G. (no. 6) | m | 6.4 | 99mTc-HMPAO | 0.39 |
| S.G. (no. 6) | m | 6.7 | 111In-Oxine | 1.88 |
| R.L. (no. 7) | m | 4 | 99mTc-HMPAO | 0.95 |
| G.D. (no. 8) | m | 4 | 99mTc-HMPAO | 1.02 |
UPTAKE RATIO: mDC/iDC 111In-Oxine average: 6 (range 4–7) 99m Tc-HMPAO average: 8.4 (range 2–35) *Maximum uptake = maximum lymph node activity/ inoculation site activity at 0 h